Insider Transactions in Q1 2025 at Genelux Corp (GNLX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 14
2025
|
Sean Ryder General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
10,708
+17.05%
|
-
|
|
Mar 14
2025
|
Tony Yu VP, Clinical Trial Operations |
BUY
Grant, award, or other acquisition
|
Direct |
13,350
+20.05%
|
-
|
|
Mar 14
2025
|
Joseph Cappello VP, Pharmaceutical Development |
BUY
Grant, award, or other acquisition
|
Direct |
13,350
+18.98%
|
-
|
|
Mar 14
2025
|
Ralph Smalling Head of Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
4,172
+10.38%
|
-
|
|
Mar 14
2025
|
Thomas Zindrick President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
30,339
+13.05%
|
-
|